Ageing Inequality in the UK: Longevity or Luxury?
- Juvenology Clinic
- 3 days ago
- 11 min read
I want to start with something that bothers me professionally.
Longevity medicine, the science of slowing biological ageing, extending healthspan, and maintaining vitality across the decades, is increasingly being positioned as a product for the wealthy. Six-figure biohacking protocols. Private members clubs in London and Geneva. Blood testing panels that cost more than a month's rent.
I understand how this happened. Longevity medicine is new. New medicine is expensive before it becomes widely available. The equipment costs are real, the expertise is rare, and the market follows the money.
But here is what I cannot accept: the positioning of longevity as inherently elite. The framing of healthy ageing as something that belongs to people who can afford it. Because that framing is not just commercially irritating. It is scientifically dishonest.
The biology of ageing does not discriminate by income. Cortisol damages collagen in working-class bodies and executive bodies equally. Inflammaging accumulates in deprived postcodes and wealthy ones alike, and research now consistently shows it accumulates faster in the deprived ones. The science of how to slow biological deterioration is published in open-access journals that anyone can read. It belongs to everyone.
That is why I built Juvenology the way I did. And it is what this article is about.
The two-tier longevity system that is already developing
The language of longevity medicine has filtered into public consciousness remarkably quickly. Healthspan. Biological age. Inflammaging. Senescence. Concepts that lived only in academic journals a decade ago are now discussed in mainstream media, in workplace wellness programmes, and in the conversations patients bring to my clinic.
But access to the interventions that actually address these concepts remains sharply unequal.
A 2025 peer-reviewed paper in the Journal of Global Health identified the emergence of a two-tiered longevity system. Those with higher incomes enjoy longer and healthier lives through better access to preventive healthcare, advanced medical treatments, and supportive lifestyles. Disadvantaged populations, meanwhile, face prolonged periods of poor health and limited access to the interventions that enhance healthspan. This is not a prediction. It is a documented trend.
The Centre for Ageing Better's State of Ageing 2025 report documented the scale of healthy life expectancy inequality across England. There is a clear north-south divide in average life expectancy at birth.
The places with the highest prevalence of poor health are not necessarily the oldest places. They are the most economically deprived ones.
The biology of ageing does not just vary by age. It varies by postcode. Kensington and Chelsea has one of the highest life expectancies for women while Richmond upon Thames has one of the highest for men.
The healthy life expectancy gap in England by deprivation
Most deprived areas | Least deprived areas | Gap | |
Life expectancy (men) | 73.5 years | 83.2 years | 9.7 years |
Life expectancy (women) | 78.3 years | 86.3 years | 8.0 years |
Healthy life expectancy (men) | ~64 years | ~82 years | ~18 years |
Healthy life expectancy (women) | 51.9 years | 70.7 years | 18.8 years |
% of life spent in good health (men) | 70.4% | 84.5% | 14.1 points |
% of life spent in good health (women) | 65.1% | 81.5% | 16.4 points |
Sources: ONS Health State Life Expectancies by Deprivation, 2020–2022; Health Foundation, 2025
This matters enormously for how we think about longevity medicine and who it is actually for.
What drives accelerated biological ageing in deprived communities
I want to be specific about this because the mechanism is important and it connects directly to the clinical science I practice every day.
Chronic psychological stress is one of the most powerful drivers of accelerated biological ageing. As I wrote in my article on cortisol and skin ageing, elevated cortisol directly degrades collagen through the upregulation of matrix metalloproteinases, impairs barrier function, suppresses fibroblast activity, and drives the chronic inflammatory cascade we call inflammaging. A 2025 study confirmed that moderately stressed subjects showed a 32.9% increase in fine lines and roughness compared to mildly stressed subjects, alongside an 80% reduction in key wound healing gene expression.
The patients experiencing the highest chronic stress are not, on average, the ones who can most easily access solutions for it. Financial anxiety, work precarity, housing insecurity, and caregiving demands are among the most potent drivers of sustained HPA axis activation.
These are not equally distributed across society. They never have been.
Poor sleep compounds this. Consistently inadequate sleep elevates inflammatory markers, disrupts cortisol regulation, impairs cellular repair, and accelerates biological ageing measurably.
The conditions that make quality sleep difficult, shift work, noisy environments, financial anxiety, overnight caregiving for dependants, are themselves associated with economic disadvantage.
Processed food diets drive inflammaging directly. Ultra-processed foods are cheaper and more accessible than fresh whole foods across much of the UK. The dietary patterns most associated with chronic low-grade inflammation are the same patterns most prevalent in economically deprived communities.
UPF consumption and deprivation in the UK
Most deprived areas | Least deprived areas | |
UPF consumption pattern | Highest in Northern England, Northern Ireland, Wales | Lowest in South England and London |
Overweight/obesity prevalence | 72% of most deprived decile | 58% of least deprived decile |
Key driver | UPF marketed aggressively to budget-constrained households; perceived as cost-saving | Greater access to fresh whole foods and supportive food environments |
Regional pattern | North East England, Yorkshire, Wales highest UPF consumption | South East, London lowest |
Structural factor | Food environment structured against healthy choice, not individual preference | More supermarkets with fresh food; less fast food density |
Sources: Cambridge Core Public Health Nutrition 2025; Obesity Reviews 2024 (Wiley); University of Cambridge/Bristol NDNS 2024
As I wrote in my article on inflammaging, chronic inflammation is the common biological thread running through almost every age-related disease: cardiovascular disease, type 2 diabetes, dementia, cancer. And it accumulates faster in bodies under sustained economic stress.
Inflammaging driver | How deprivation increases exposure | UK evidence |
Chronic stress | Financial insecurity, housing instability, work precarity drive sustained HPA axis activation | Chronic stress linked to 32.9% increase in fine lines and 80% reduction in wound healing gene expression (2025 study) |
Poor sleep | Shift work, noisy environments, overnight caregiving, financial anxiety all impair sleep quality | Sleep deprivation elevates inflammatory markers and accelerates biological ageing measurably |
Ultra-processed food diet | UPF consumption highest in most deprived areas; lowest in South England/London where income is highest | 72% of most deprived decile living with overweight or obesity vs 58% of least deprived (2021 data, Obesity Reviews) |
Physical inactivity | Fewer green spaces, longer working hours, more physically demanding jobs leaving less capacity for exercise | Physical activity levels consistently lower in deprived areas across UK data |
Environmental pollution | Higher exposure to air pollution, noise pollution in deprived urban areas | Cumulative UV and environmental damage drives higher inflammasome activity |
Hormonal disruption | Later access to hormonal health support; perimenopause less likely to be discussed or treated | Perimenopausal women in deprived areas less likely to receive HRT or specialist care |
Sources: House of Commons Library Health Inequalities Briefing 2025; Obesity Reviews 2024; ONS Health Inequalities data; Cambridge/Bristol NDNS study 2024
The science of longevity is not describing a natural difference in how different people age. It is describing the biological consequences of inequality. That is a moral problem as much as a medical one.
What this means for how I practice
The communities I work with deserve the same quality of clinical thinking and evidence-based care that any Harley Street patient receives. That conviction has shaped everything about how Juvenology is built.
It shapes how I price treatments. It shapes what I write on this blog.
It shapes the free longevity protocol I published recently, which lays out everything the science supports for slowing biological ageing without spending a penny. Not as a marketing exercise. As a genuine commitment to the idea that information is a form of healthcare.
It shapes how I approach consultations. I do not assume that the goal of a consultation is always to recommend a treatment. Sometimes the most valuable thing I can offer is an honest assessment of what someone needs, whether that is a clinical intervention or simply a clearer understanding of what their biology is doing and why.
Those conversations are worth having regardless of what follows commercially.
And it shapes the philosophy I want Juvenology to represent: that longevity medicine is not a product for the elite. It is a body of knowledge that belongs to everyone.
The honest case for clinical treatments within a democratic framework
I want to be direct about something that might feel contradictory. Juvenology is a clinic. I offer treatments that cost money. I am not pretending otherwise but I think there is a coherent and honest way to hold both positions simultaneously.
The most powerful longevity interventions are free. Sleep. Movement. Stress management. Daily SPF. Adequate protein. Resistance training. These are not consolation prizes for people who cannot afford clinic appointments. They are the foundation on which all other longevity investment rests, including investment in clinical treatments.
What clinical treatments offer, specifically the regenerative treatments at the heart of what I do at Juvenology, is targeted biological support for mechanisms that are declining faster than lifestyle interventions alone can compensate for. The polynucleotides that activate fibroblasts directly. The Profhilo that restores the tissue environment. The blood tests that make the invisible visible, showing where the systemic biology is working against you and where targeted clinical support would make the biggest difference.
These things are worth investing in when they are accessible. Making them accessible to more people, pricing thoughtfully, explaining honestly, not upselling where it is not warranted, is part of what I mean by democratic longevity in practice.
I want to say something that is commercially inconvenient but clinically honest. Every clinic I am aware of, including this one, benefits commercially from patients who invest in treatments without yet optimising the free interventions that would make those treatments more effective. The genuinely ethical thing to do is tell patients that, even when it complicates the revenue conversation. At Juvenology, that is the principle we try to practice.
Whether we always get it right, I cannot say. But it is the standard I hold myself to.
What I would like to see change in this industry
I am one practitioner in one clinic in one Kent market town. I do not have the platform to restructure an industry. But I can say clearly what I think needs to change.
Longevity medicine needs to get better at separating what the science actually supports from what the market has attached to the language of longevity for commercial reasons. Not every supplement described as longevity-supporting has meaningful evidence. Not every blood panel marketed as a biological age assessment is doing what it claims. The commercial momentum behind longevity medicine has moved significantly faster than the evidence base for some of its most expensive offerings.
The longevity medicine community needs to centre health equity in a way it currently does not. The populations accumulating the greatest biological age deficits are not the ones filling longevity clinics. They are the ones least likely to encounter this language at all. Reaching them requires a deliberate commitment to accessibility, in language, in pricing, in the content we publish, and in the communities we choose to serve.
The ILC UK Future of Ageing 2026 report frames this as one of the defining challenges of the coming decade. Acting now for longer, better lives for all is the language they use. All. Not some. Not the affluent. All.
What democratic longevity looks like in practice
Let me be concrete rather than abstract.
Democratic longevity means publishing the science behind ageing in plain English, for free, without a paywall or a membership fee. Which is what this blog is.
It means explaining the free longevity protocol with the same rigour I bring to clinical treatment protocols. Because sleep and movement and stress management and daily SPF have as much peer-reviewed evidence behind them as many of the treatments I offer in clinic.
It means being honest when someone comes to me for a treatment and what they actually need is a better understanding of their biology first. A blood test panel that gives measurable information about systemic inflammation, hormonal status, and nutritional adequacy might tell someone more useful information about their ageing biology than a course of treatments costing ten times that, if the systemic picture is the real issue.
It means designing treatment protocols around what patients actually need rather than what generates the highest revenue per appointment.
And it means saying clearly, in writing, on a public blog, that the longevity industry has a problem with access and equity that the clinical community is not doing enough to address. Who is longevity medicine actually for? And who is it leaving behind?
The answer right now is too often: the wealthy. That needs to change.
Frequently asked questions
Is longevity medicine actually accessible without a large budget? Yes, substantially. The most evidence-backed longevity interventions, quality sleep, regular movement, stress management, anti-inflammatory diet, daily SPF, and resistance training, are free. Clinical treatments add targeted biological support for specific declining mechanisms but they work best as enhancements to a strong free foundation, not substitutes for it.
What is the free longevity protocol? It is a structured guide I published covering everything the peer-reviewed evidence supports for slowing biological ageing without spending anything. You can read it at Juvenology's free longevity protocol. It is written with the same clinical rigour as any treatment protocol.
Why does socioeconomic status affect biological ageing? Primarily through the biological mechanisms of chronic stress, poor sleep, inflammatory diets, and reduced physical activity. These are more prevalent in economically deprived communities because of structural conditions, not personal choices in a vacuum. The result is measurably accelerated biological ageing in populations that already face the greatest health disadvantages.
How does Juvenology try to make longevity medicine more accessible? Through transparent pricing, honest consultations that prioritise patient need over revenue, free educational content on this blog, and a commitment to explaining the science in plain English regardless of whether it leads to a booking. We are not perfect at this but it is the standard we hold ourselves to.
What is the single most important free longevity intervention? Sleep, consistently and by a significant margin. Seven to nine hours of quality sleep is when the body performs its most critical cellular repair, inflammatory resolution, and hormonal regulation. Everything else in longevity medicine works better when sleep is adequately prioritised. If you do nothing else, protect your sleep.
Book your consultation at Juvenology, Maidstone
If you would like to understand your own biology and what it needs, regardless of your budget, that conversation starts with a consultation at Juvenology. We will look at what the science says before we recommend anything. And if the answer is that you need better sleep and a clearer understanding of your inflammatory drivers before any clinical treatment, that is what we will tell you.
I came from cardiac nursing. I watched what happened when people did not have access to the information that could have changed their outcomes. Not expensive technology. Just information, understood clearly, acted upon early. Longevity medicine is at risk of becoming the preserve of the privileged. I think that is a waste of some of the most important science of our generation. And I think it is wrong.
About the author
Marina is the founder of Juvenology Clinic in Maidstone, Kent, and a longevity medicine practitioner serving patients across Kent. With over 25 years of nursing experience including cardiac care at KIMS Hospital, an EMSc in Longevity from the Geneva College of Longevity Science, and a qualification in Hormonal Health and Bioidentical Hormone Therapy from the Marion Gluck Academy, she brings a genuinely medical perspective to aesthetic practice, one shaped by years in cardiovascular medicine where evidence-based protocols and anatomical precision are non-negotiable.
Marina is NMC Registered, BACN Member, JCCP Verified, ACE Group Registered, a Member of the Royal College of Nursing, ICO Registered, and registered with the Professional Standards Authority. Juvenology is based in Maidstone and serves patients across Kent including Tunbridge Wells, Sevenoaks, Kings Hill, West Malling, and beyond.
From anti-wrinkle injections and dermal fillers to advanced regenerative treatments and longevity medicine, Marina combines rigorous medical knowledge with a nurturing, patient-centred approach.
References
Journal of Global Health, lifespan versus healthspan, the two-tier longevity system, 2025: https://pmc.ncbi.nlm.nih.gov/articles/PMC12068195/
Centre for Ageing Better, State of Ageing 2025, health and wellbeing inequalities: https://ageing-better.org.uk/health-and-wellbeing-state-ageing-2025
ILC UK, Future of Ageing 2026, acting now for longer better lives for all: https://ilcuk.org.uk/future-of-ageing-2026/
NHS, health inequalities in England: https://www.nhs.uk/our-nhs-structure/national-organisations/nhs-england/our-priorities/prevention-and-health-inequalities/